Japanese Generics Makers Slow To Add Rep Staff To Boost Sales

Generics makers may be missing the added sales encouraged by Japan's goal of 30 percent use, by short-staffing their sales forces. Makers of branded drugs still employ far more medical representatives than their generics rivals. Takeda Pharmaceutical has 2,000 while generics companies Towa Pharmaceutical and Sawai Pharmaceutical had only 420 and 341, respectively, at the end of March. (Click here for more - a subscription may be required